My long-term goal is to explore the link between obesity, insulin resistance, and hypertension in humans. Obesity is associated with increased levels of sympathetic activity, which may be a risk factor in the development of hypertension. Obesity is also associated with insulin resistance. Since obesity does not always result in hypertension, and increased levels of sympathetic activity are not always associated with hypertension, this raises the possibility that increased sympatetic activity and insulin resistance interact to promote hypertension in obese humans. Further, insulin is a potent vasodilator that can blunt sympathetic vasoconstriction in normal subjects. Thus, the development of insulin resistance in conjunction with increased sympathetic activity might promote the development of hypertension in the obese individual. In this context, it is possible that the relation between sympathetic nerve activity and vascular resistance is altered by the development of insulin resistance in obese individuals to favor vaso constriction. Therefore, we speculate that sympathetic vasoconstriction will be greater and vascular resistance will be higher in obese individuals because insulin resistance blunts the vasodilatory actions of insulin, permitting unopposed sympathetic vasoconstriction to occur. If so, this might be a key factor which links obesity, augmented sympathetic activity, and insulin resistance in the development of hypertension in obese humans. In this proposal we will tes the idea that insulin resistance exacerbates the hypersive effects of increased sympathetic nerve activity in viscerally obese indviduals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32DK009826-02
Application #
2905170
Study Section
Special Emphasis Panel (ZRG2-MET (02))
Program Officer
Hyde, James F
Project Start
1999-07-01
Project End
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Torp, K D; Tschakovsky, M E; Halliwill, J R et al. (2001) beta-Receptor agonist activity of phenylephrine in the human forearm. J Appl Physiol 90:1855-9
Weisbrod, C J; Minson, C T; Joyner, M J et al. (2001) Effects of regional phentolamine on hypoxic vasodilatation in healthy humans. J Physiol 537:613-21
Klein, C J; Silber, M H; Halliwill, J R et al. (2001) Basal forebrain malformation with hyperhidrosis and hypothermia: variant of Shapiro's syndrome. Neurology 56:254-6
Halliwill, J R; Minson, C T; Joyner, M J (2000) Effect of systemic nitric oxide synthase inhibition on postexercise hypotension in humans. J Appl Physiol 89:1830-6
Joyner, M J; Halliwill, J R (2000) Sympathetic vasodilatation in human limbs. J Physiol 526 Pt 3:471-80